Literature DB >> 12164929

Relationship between p53 codon 72 polymorphism and susceptibility to sunburn and skin cancer.

Jane M McGregor1, Catherine A Harwood, Louise Brooks, Sheila A Fisher, Deirdre A Kelly, Jenny O'nions, Antony R Young, Thiru Surentheran, Judith Breuer, Thomas P Millard, Cathryn M Lewis, Irene M Leigh, Alan Storey, Timothy Crook.   

Abstract

Upregulation of p53 protein induces either growth arrest or apoptosis in response to cellular injury This is signaled from a highly conserved p53 domain between codons 64 and 92, where a functional polymorphism results in either a proline (p53-72P) or an arginine (p53-72R) at codon 72. Preliminary studies suggest that p53-72R may be a risk factor for cervical cancer and, consistent with this, preferential mutation and retention of the p53-72R allele has also been demonstrated in other cancers of squamous cell origin. Here we examine the relationship between allelic forms of p53 and nonmelanoma skin cancer, by determining the correlation with susceptibility to sunburn, which is a known risk factor, and then by p53 sequence analysis of a large series of tumors. We found a significant positive association between p53-72R and susceptibility to sunburn, as assessed by skin phototype and minimal erythemal dose following solar-simulated radiation (p = 0.0001 for trend). We also found a significant association between p53-72R homozygosity and nonmelanoma skin cancer in renal transplant recipients (basal cell carcinoma, p < 0.01; squamous cell carcinoma, p < 0.05) but not in immunocompetent patients compared with skin type matched controls. p53 sequence data revealed mutations in 30 of 70 (42.9%) nonmelanoma skin cancers, 28 (93%) of which were in the p53-72R allele. Loss of heterozygosity occurred more frequently in p53-72RP than in p53-72RR tumors (p = 0.0001) with preferential loss of p53-72P in heterozygotes (p = 0.016), irrespective of the mutant status of the concomitant allele. Together these data infer functional differences between polymorphic forms of p53 that are likely to be relevant to skin carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164929     DOI: 10.1046/j.1523-1747.2002.01655.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  19 in total

Review 1.  DNA damage, apoptosis and langerhans cells--Activators of UV-induced immune tolerance.

Authors:  Laura Timares; Santosh K Katiyar; Craig A Elmets
Journal:  Photochem Photobiol       Date:  2008-01-29       Impact factor: 3.421

2.  Genetic association between p53 codon 72 polymorphism and risk of cutaneous squamous cell carcinoma.

Authors:  Ting Liu; Zeyuan Lei; ZhengYing Pan; Yu Chen; Xiang Li; TongChun Mao; Qian He; Dongli Fan
Journal:  Tumour Biol       Date:  2013-12-20

Review 3.  p53 and the pathogenesis of skin cancer.

Authors:  Cara L Benjamin; Honnavara N Ananthaswamy
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-15       Impact factor: 4.219

4.  p53 Arg72Pro polymorphism and risk of basal cell carcinoma: a meta analysis.

Authors:  Yanli Tian; Li Li; Rongya Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

5.  The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer.

Authors:  Lindsay M Almquist; Margaret R Karagas; Brock C Christensen; Marleen M Welsh; Ann E Perry; Craig A Storm; Heather H Nelson
Journal:  Carcinogenesis       Date:  2010-12-01       Impact factor: 4.944

6.  Mouse models for the p53 R72P polymorphism mimic human phenotypes.

Authors:  Feng Zhu; Martijn E T Dollé; Thomas R Berton; Raoul V Kuiper; Carrie Capps; Alexsandra Espejo; Mark J McArthur; Mark T Bedford; Harry van Steeg; Annemieke de Vries; David G Johnson
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

Review 7.  Basal cell carcinomas: attack of the hedgehog.

Authors:  Ervin H Epstein
Journal:  Nat Rev Cancer       Date:  2008-10       Impact factor: 60.716

Review 8.  The genetics of sun sensitivity in humans.

Authors:  Jonathan L Rees
Journal:  Am J Hum Genet       Date:  2004-09-15       Impact factor: 11.025

Review 9.  Genetic Modifiers of the p53 Pathway.

Authors:  Subhasree Basu; Maureen E Murphy
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

10.  Identification of colorectal cancer patients with tumors carrying the TP53 mutation on the codon 72 proline allele that benefited most from 5-fluorouracil (5-FU) based postoperative chemotherapy.

Authors:  Ten-i Godai; Tetsuji Suda; Nobuhiro Sugano; Kazuhito Tsuchida; Manabu Shiozawa; Hironobu Sekiguchi; Akiko Sekiyama; Mitsuyo Yoshihara; Shoichi Matsukuma; Yuji Sakuma; Eiju Tsuchiya; Yoichi Kameda; Makoto Akaike; Yohei Miyagi
Journal:  BMC Cancer       Date:  2009-12-02       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.